DK1173476T3 - Funktionelle sojabönneproteiner - Google Patents

Funktionelle sojabönneproteiner

Info

Publication number
DK1173476T3
DK1173476T3 DK00930241T DK00930241T DK1173476T3 DK 1173476 T3 DK1173476 T3 DK 1173476T3 DK 00930241 T DK00930241 T DK 00930241T DK 00930241 T DK00930241 T DK 00930241T DK 1173476 T3 DK1173476 T3 DK 1173476T3
Authority
DK
Denmark
Prior art keywords
lunasin
polypeptide
provides methods
unit dosage
active unit
Prior art date
Application number
DK00930241T
Other languages
English (en)
Inventor
Lumen Benito O De
Alfredo F Galves
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK1173476T3 publication Critical patent/DK1173476T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/56—Protease inhibitors from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Tea And Coffee (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Fodder In General (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK00930241T 1999-04-30 2000-04-30 Funktionelle sojabönneproteiner DK1173476T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/303,814 US6391848B1 (en) 1999-04-30 1999-04-30 Soybean protein nutraceuticals
PCT/US2000/011657 WO2000066625A1 (en) 1999-04-30 2000-04-30 Soybean protein nutraceuticals

Publications (1)

Publication Number Publication Date
DK1173476T3 true DK1173476T3 (da) 2007-02-19

Family

ID=23173833

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00930241T DK1173476T3 (da) 1999-04-30 2000-04-30 Funktionelle sojabönneproteiner

Country Status (11)

Country Link
US (1) US6391848B1 (da)
EP (1) EP1173476B1 (da)
JP (1) JP3850667B2 (da)
AT (1) ATE342276T1 (da)
AU (1) AU762977B2 (da)
CA (1) CA2365266C (da)
DE (1) DE60031259T2 (da)
DK (1) DK1173476T3 (da)
ES (1) ES2273693T3 (da)
PT (1) PT1173476E (da)
WO (1) WO2000066625A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1268534A2 (en) * 2000-03-24 2003-01-02 Filgen Biosciences, Inc. Peptides binding to non-acetylated h3 and h4 histones for cancer therapy
KR101348530B1 (ko) * 2003-11-06 2014-02-14 다니스코 유에스 인크. 프로테아제 저해자 및 그 변이체의 사상균 내에서의 발현
WO2005091823A2 (en) * 2004-03-01 2005-10-06 The Regents Of The University Of California The use of lunasin peptide as a transcriptional activator to prevent cancer and related methods for treatment, monitoring and prognosis
US20070054031A1 (en) * 2005-09-02 2007-03-08 Keshun Liu Methods of extracting, concentrating and fractionating proteins and other chemical components
US20090113889A1 (en) * 2006-02-28 2009-05-07 Subir Roychoudhury Catalytic burner for stirling engine
US8598111B2 (en) * 2006-09-15 2013-12-03 Soy Labs, Llc Products and methods using soy peptides to lower total and LDL cholesterol levels
US7731995B2 (en) * 2006-09-16 2010-06-08 Alfredo Flores Galvez Methods for using soy peptides to inhibit H3 acetylation, reduce expression of HMG CoA reductase, and increase LDL receptor and Sp1 expression in a mammal
CN101522022B (zh) 2006-09-16 2013-05-08 大豆实验室公司 利用大豆肽降低总胆固醇水平和ldl胆固醇水平的产品和方法
US8759613B1 (en) 2009-10-26 2014-06-24 University Of Louisville Research Foundation, Inc. Method of producing a lunasin polypeptide in plants
US9066906B2 (en) * 2009-11-11 2015-06-30 University Of Louisville Research Foundation, Inc. Lunasin-containing complex and purification of lunasin from plants
WO2014145086A2 (en) 2013-03-15 2014-09-18 Galvez Alfredo Flores Products and methods using lunasin-enriched soy extract mixtures to reduce free fatty acid levels, increase leptin levels and increase adiponectin levels in plasma
CN108034670B (zh) * 2017-12-25 2021-03-30 大连大学 一种食源性大豆生物活性肽Lunasin的无柱式、低成本制备方法
PL447389A1 (pl) * 2023-12-29 2025-06-30 Pharmacy Research Institute Spółka Z Ograniczoną Odpowiedzialnością Sposób pozyskiwania preparatu o podwyższonej zawartości lunazyny

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217717A (en) * 1990-09-06 1993-06-08 Central Soya Company, Inc. Method of making soybean Bowman-Birk inhibitor concentrate and use of same as a human cancer preventative and therapy
US5614198A (en) * 1995-07-25 1997-03-25 The Trustees Of The University Of Pennsylvania Bowman-Birk Inhibitor compositions for treatment of inflammatory disease
US5850016A (en) * 1996-03-20 1998-12-15 Pioneer Hi-Bred International, Inc. Alteration of amino acid compositions in seeds
US6107287A (en) * 1997-09-25 2000-08-22 The Regents Of The University Of California Lunasin peptides

Also Published As

Publication number Publication date
PT1173476E (pt) 2007-01-31
CA2365266C (en) 2010-10-12
DE60031259T2 (de) 2007-04-12
JP3850667B2 (ja) 2006-11-29
CA2365266A1 (en) 2001-10-09
EP1173476A4 (en) 2002-08-28
EP1173476A1 (en) 2002-01-23
US6391848B1 (en) 2002-05-21
JP2002543219A (ja) 2002-12-17
AU762977B2 (en) 2003-07-10
ES2273693T3 (es) 2007-05-16
ATE342276T1 (de) 2006-11-15
WO2000066625A1 (en) 2000-11-09
EP1173476B1 (en) 2006-10-11
DE60031259D1 (de) 2006-11-23
AU4809600A (en) 2000-11-17

Similar Documents

Publication Publication Date Title
EP3001990A1 (en) A mixture for transdermal delivery of low& and high molecular weight compounds
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
DK1173476T3 (da) Funktionelle sojabönneproteiner
BR0108173A (pt) Composições farmacêuticas de toxina de botulina
ATE75945T1 (de) Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
FI974385A0 (fi) Anvaendning av xylitol foer bekaempning av jaestinfektion och xylitolpreparat foer denna anvaendning
KR20190101990A (ko) 펩티드 wkdeagkplvk를 포함하는 조성물
AR017973A1 (es) Formulacion farmaceutica isotonica, uso de dicha formulacion en la preparacion de un medicamento para uso en la terapia de una enfermedad autoinmune,y metodo para mejorar el almacenamiento de un anticuerpo
ES2327640T3 (es) Sustancias biologicamente activas a partir de un peptido intestinal vasoactivo para el tratamiento de afecciones pulmonares intersticiales.
ATE392428T1 (de) Arzneimittel enthaltend analgetische peptide
NO20042055L (no) Tymosinalfa 1-peptid/polymerkonjugater
BRPI0412430A (pt) polipeptìdeo agonista do receptor de zot e zonulina
JP2002530353A5 (da)
NO20042100D0 (no) Fremgangsmate for administrering av et tymosinalfa 1-peptid
WO1990004977A3 (en) Treatment of genital warts with a combination of liquid nitrogen and recombinant dna human alpha interferon
AU3739500A (en) Protease resistant flint analogs
WO2004028457A3 (en) PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY
BR9917605A (pt) Composição substituta de plasma
GB2616223A9 (en) Oral formulation of biologically active material conjugate having biotin moiety, fatty acid moiety, or combination thereof coupled thereto
ITAP20140004U1 (it) Acido ialuronico ad alto peso molecolare in spray
YU17703A (sh) Nova farmaceutska kompozicija za primenu na koži
HK1102290B (en) A mixture for transdermal delivery of low and high molecular weight compounds